Sanofi said on Monday it had entered exclusive talks for the sale of a 50% controlling stake in its consumer health business ...

Sanofi entered into exclusive talks to sell a controlling stake in its consumer-healthcare business Opella to Clayton ...

Clayton Dubilier & Rice is nearing a deal to acquire control of Sanofi’s consumer health unit after the American buyout firm ...

Sanofi and CD&R partner to fuel Opella’s ambitions in consumer healthcareSanofi and CD&R enter exclusive negotiations to transfer a 50% ...

Dow Jones Newswires is a market-moving financial and business news source, used by wealth managers, institutional investors and fintech platforms around the world to identify trading and investing ...

Clayton Dubilier & Rice is set to buy Sanofi's consumer health unit with social commitments, including job creation ...

France will take a stake in Sanofi’s Opella through the Public Investment Bank, or BPI, finance minister Antoine Armand said on Sunday, confirming an information from Le Figaro ...

Beyond getting countries to commit to conservation policies and plans, a top priority for the COP16 summit is finding new ...

PARIS ― The French government said Sunday it is backing the sale of a subsidiary of pharmaceuticals multinational Sanofi that ...

category Sanofi enters exclusive talks with CD&R for Opella sale 5:32 AM UTC · Updated ago Macro Matterscategory IMF, World ...

Recent updates in health include Hong Kong's ongoing monkey deaths due to melioidosis, Egypt's certification as malaria-free ...

The proposed sale turned into a real political issue because Opella's products include Doliprane, the best-selling medicine ...